Keyword: Olivier Brandicourt

Sanofi

7. Sanofi

Sanofi had a bit of a year to forget when it came to buying up biotechs and expanding its pipeline—it failed to beat out Pfizer in its winning $14 billion bid for cancer biotech Medivation, losing out on some increasingly hot cancer candidates and blockbuster prostate cancer med Xtandi.